SenesTech

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

SenesTech reports record revenue growth driven by Evolve product launch

SenesTech's Q1 2024 performance was driven by the successful launch of Evolve, leading to record revenue growth. The company's strengths lie in expanding distribution channels and focusing on operational efficiencies. Challenges include achieving positive cash flow and balancing sales channels, while opportunities exist in capturing a larger market share with Evolve mouse and leveraging the Amazon store launch.

SenesTech achieves record revenue and margin growth, eyes global expansion

SenesTech delivered strong financial performance with record revenue and improved margins.
The company's product portfolio and expansion strategies position it for continued growth.
Challenges include maintaining profitability, managing competition, and balancing growth with financial stability.
Opportunities exist in market penetration, partnerships, and global expansion initiatives.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The firm focuses on rat populations through fertility control. It offers its ContraPest product to residential and commercial sectors such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer on July 27, 2004 and is headquartered in Phoenix, AZ.

SenesTech, Inc. (SNES) CEO Kenneth Siegel on Q4 2021 Results - Earnings Call Transcript

Product Sales up 123% as the Company Drives ContraPest® Deployment in New and Existing Market Verticals PHOENIX , March 29, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, announced today that revenues for 2021 more than doubled compared to last year as the Company accelerated penetration in existing markets and expanded into a number of new market verticals. Since the end of 2021, the Company has announced a number of key deployments in government applications, accelerating penetration as more cities and counties recognize the growing success of ContraPest through media reports and marketing efforts.

SenesTech Announces Year-End 2021 Financial and Operational Results

Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , March 23, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2021, ended December 31, 2021, after the market close on Tuesday, March 29, 2022. The Company has scheduled a conference call that same day, Tuesday, March 29, 2022, at 5:00 pm ET, to review the results.

SenesTech to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Tuesday, March 29, 2022

SenesTech Inc (NASDAQ: SNES) shares are trading higher by 22.2% at $0.88 after the company announced the EPA approval of and launch of the Elevate Bait System with ContraPest. SenesTech says the bait system is specifically designed to be easily deployed above ground with multiple options for.

Here's Why SenesTech Shares Are Rising

The Elevate Bait System with ContraPest is specifically designed to address rat problems in above-ground locations. PHOENIX , March 22, 2022 /PRNewswire/ -- SenesTech, Inc., (SNES) announced today the EPA approval of and launch of its newest product design and application, the Elevate Bait System™ with ContraPest®.

SenesTech, Inc., Announces EPA Approval and Launch of the Elevate Bait System™ with ContraPest®

PHOENIX, Feb. 24, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com), the rodent fertility control expert announced today the deployment of ContraPest® at a correctional facility, the first such deployment into a large customer segment. This 2,500 bed, medium security facility encompasses approximately 20 acres and a dozen plus structures and has the added challenge of being near waste transfer facilities.

SenesTech Announces ContraPest® Deployment at a Major Correctional Facility

PHOENIX, Feb. 3, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) ( www.senestech.com ), the rodent fertility control expert announced today the deployment of ContraPest® at Safari West Wildlife Preserve in northern California. It is a 400-acre private wildlife preserve and tent camp just outside Santa Rosa California.

SenesTech Announces ContraPest® Deployment at California Wildlife Preserve

PHOENIX, Jan. 25, 2022 /PRNewswire/ -- SenesTech (NASDAQ: SNES) ( www.senestech.com ), the rodent fertility control expert, announced today that Columbus, Ohio is the latest city to begin using ContraPest®. Columbus now joins cities like San Francisco, Washington DC, Hartford, and Newton, Massachusetts in successfully incorporating ContraPest into their integrated pest management programs, with others expected to follow.

Columbus, Ohio Joins a Growing Number of Cities Across the United States Deploying SenesTech's ContraPest® as Part of Their Pest Management Programs

PHOENIX, Dec. 6, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking place from December 13-16, 2021. During the event, the company will be participating in a webcasted Fireside Chat discussing its vision for 2022 and conducting 1x1 virtual investor meetings.

SenesTech to Participate in the Lytham Partners Winter 2021 Investor Conference

SenesTech's (SNES) CEO Ken Siegel on Q3 2021 Results - Earnings Call Transcript

PHOENIX, Nov. 10, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest®, announced today revenues for the third quarter of 2021 more than doubled compared to the same period a year ago, and are up 14% sequentially. Year-to-date nine-month revenues were also more than double the same period last year.

SenesTech Announces 2021 Third Quarter Financial and Operational Results

PHOENIX, Nov. 3, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its third quarter 2021, ended September 30, 2021, after the market close on Wednesday, November 10, 2021. The Company has scheduled a conference call that same day, Wednesday, November 10, 2021, at 5:00 pm ET, to review the results.

SenesTech to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021

PHOENIX, Oct. 26, 2021 /PRNewswire/ -- Just one year since SenesTech  (NASDAQ: SNES) (www.senestech.com), the rodent fertility control experts, transitioned from a science-based research company to a commercial one, municipalities around the United States are using its rat contraceptive, ContraPest®  as they work to combat soaring rat populations. Newton, Massachusetts now joins other cities like Hartford, San Francisco, and Washington DC successfully incorporating ContraPest® into their pest management programs.

Newton, Massachusetts Joins Cities Across the U.S. Using ContraPest® to Control Soaring Rat Populations

PHOENIX, Sept. 30, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on Thursday, October 7, 2021 at 3:30pm ET.

SenesTech to Present at the Lytham Partners Fall 2021 Investor Conference

SenesTech's (SNES) CEO Ken Siegel on Q2 2021 Results - Earnings Call Transcript

PHOENIX, Aug. 12, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"),  (www.senestech.com) the rodent fertility control experts and inventors of the first and only EPA registered rat contraceptive, ContraPest®, announced today revenues for the second quarter of 2021 increased 125% from the same period a year ago, and are up 82% sequentially. Year to date, revenues have increased 130% from the same period last year.

SenesTech Announces 2021 Second Quarter Financial and Operational Results

PHOENIX, Aug. 3, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its second quarter 2021, ended June 30, 2021, after the market close on Thursday, August 12, 2021. The Company has scheduled a conference call that same day, Thursday, August 12, 2021, at 5:00 pm ET, to review the results.

SenesTech to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021

Advaxis

Second Sight Medical Products

Rigel Pharmaceuticals

Biotech penny stocks continue to climb, which companies are on your watchlist? The post Top Biotech Penny Stocks to Buy This Week?

Top Biotech Penny Stocks to Buy This Week? 9 To Watch

PHOENIX, June 11, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Spring 2021 Investor Conference on Tuesday, June 15, 2021 at 11:45am ET. A webcast of the presentation will be available on the Company's website at https://senestech.investorroom.com/.

SenesTech to Present at the Lytham Partners Summer 2021 Investor Conference

Senestech, Inc. (SNES) CEO Kenneth Siegel on Q1 2021 Results - Earnings Call Transcript

Shares of SenesTech (NASDAQ:SNES) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 87.36% over the past year to ($0.22), which missed the estimate of ($0.16).

SenesTech: Q1 Earnings Insights

PHOENIX, May 13, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), (www.senestech.com) the rodent fertility control experts and inventors of the first and only registered rat contraceptive, ContraPest® announced today revenues for the first quarter in 2021 were up 138 percent from the same period a year ago while operating expenses have been reduced by 20 percent. During the past year, SenesTech has transitioned from a science-based research company to a solutions-based, environmentally responsible commercial company providing a new and proven tool to pest control management for the 21st century.

SenesTech Announces 2021 First Quarter Financial and Operational Results

PHOENIX, May 5, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its first quarter 2021, ended March 31, 2021, after the market close on Thursday, May 13, 2021. The Company has scheduled a conference call that same day, Thursday, May 13, 2021, at 5:00 pm ET, to review the results.

SenesTech to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021

PHOENIX, May 5, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) announced today the launch of its new brand campaign, "The Pest Control Difference" featuring ContraPest® which is revolutionizing pest management by targeting rodent reproduction. As the industry leader in fertility management, ContraPest® is bringing to pest control a highly effective and sustainable addition to integrated pest management (IPM).

SenesTech Launches New Brand and Website for ContraPest® "The Pest Control Difference"

PHOENIX, April 20, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary, next generation technologies for managing animal pest populations through fertility control, today announced the renewal and expansion of its distribution agreement with Agri-Turf Distributing, LLC ("Agri-Turf") for the marketing, sale and distribution of ContraPest® in California. "Agri-Turf's management team has deep experience in the pest management industry, particularly in the California market, and their team believes in delivering the most innovative technology and products to their customers.

News for SenesTech Stock (SNES)